Treatment

2:52
Type 2 diabetes could be an early indicator for Alzheimer’s
Karl Herrup
3:03
Could Japanese gardens prevent the progression of Alzheimer’s?
Karl Herrup
1:15
Supporting innovation for better, more effective Alzheimer’s treatments
Susan Catalano
1:47
Synaptoprotective Sigma-2 antagonists for Alzheimer’s
Susan Catalano
1:13
Recent advances in mitophagy and age-related neurodegenerative diseases
Helene Plun-Favreau
1:24
Understanding the pathways behind selective mitophagy upregulation
Helene Plun-Favreau
1:31
The role of selective mitophagy in the pathogenesis of neurodegenerative diseases
Helene Plun-Favreau
2:00
What are the benefits of collaborating with the Drug Discovery Institute?
Amy Monaghan
1:43
The potential of the Dementias Platform UK clinical studies register
Anna Myers
1:34
Dementias Platform UK: The power of volunteers in the progression of dementia research
Anna Myers
0:41
Exploring new topic areas with the Drug Discovery Institute
Amy Monaghan
2:04
Targeting proteostasis for the treatment of neurodegenerative diseases
John Skidmore
1:35
Finding novel treatments rapidly: the ARUK Drug Discovery Alliance
John Skidmore
1:41
Progress in developing novel drugs for the treatment of dementia
John Skidmore
3:55
Clinical development of novel pharmacological treatments for Alzheimer’s disease
Jakub Hort
1:57
New approaches for developing disease modifying therapies in Alzheimer’s disease
Jakub Hort
The content of VJDementia is intended for healthcare professionals